Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Lancet Respir Med. 2014 Jun 16;2(7):557–565. doi: 10.1016/S2213-2600(14)70124-9

Table 3.

Multivariable Analysis of Transplant-free Survival of Non-IPF ILD Patients in the Dallas Cohort.

Dallas non-IPF cohort (n=187)*

Hazard Ratio (95% CI) P-value
Multivariable analysis

Age 1·03 (1·00 – 1·06) 0·065
Male Sex 3·07 (1·55 – 6·07) 0·0013
FVC, % predicted 1·06 (0·86 – 1·31) 0·59
DLCO, % predicted 0·44 (0·31 – 0·62) <0·0001
Telomere Length 0·73 (0·16 – 3·41) 0·69
*

The analysis includes patients with all covariates available.